Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease.

MLA

Marshall, Christian R., et al. “Best Practices for the Analytical Validation of Clinical Whole-Genome Sequencing Intended for the Diagnosis of Germline Disease.” NPJ Genomic Medicine, vol. 5, Oct. 2020, p. 47. EBSCOhost, https://doi.org/10.1038/s41525-020-00154-9.

APA

Marshall, C. R., Chowdhury, S., Taft, R. J., Lebo, M. S., Buchan, J. G., Harrison, S. M., Rowsey, R., Klee, E. W., Liu, P., Worthey, E. A., Jobanputra, V., Dimmock, D., Kearney, H. M., Bick, D., Kulkarni, S., Taylor, S. L., Belmont, J. W., Stavropoulos, D. J., & Lennon, N. J. (2020). Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease. NPJ Genomic Medicine, 5, 47. https://doi.org/10.1038/s41525-020-00154-9

Chicago

Marshall, Christian R, Shimul Chowdhury, Ryan J Taft, Mathew S Lebo, Jillian G Buchan, Steven M Harrison, Ross Rowsey, et al. 2020. “Best Practices for the Analytical Validation of Clinical Whole-Genome Sequencing Intended for the Diagnosis of Germline Disease.” NPJ Genomic Medicine 5 (October): 47. doi:10.1038/s41525-020-00154-9.